American Healthcare REIT vs Healthcare Realty Trust
AHR and HR side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHR and HR compare
American Healthcare REIT is the larger company, worth 1.9 times as much as Healthcare Realty Trust ($11.7B against $6.2B).
American Healthcare REIT grew revenue faster over the last twelve months (16.4% versus −5.8% for Healthcare Realty Trust).
American Healthcare REIT keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −4.0% at Healthcare Realty Trust.
Both pay dividends: American Healthcare REIT yields 1.9% and Healthcare Realty Trust 5.3%.
American Healthcare REIT scores higher on the StockData Score (11 against 5 for Healthcare Realty Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHR | HR |
|---|---|---|
| Size and price | ||
| Market cap | $11.7B | $6.2B |
| Share price | $53.52 | $18.13 |
| Change, 1 year | 20.1% | 1.1% |
| Change, 5 years | – | −44.6% |
| Beta (5Y) | 0.49 | 0.53 |
| Employees | 121 | 539 |
| StockData Score | ||
| Total score | 11 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 4 (better) | 1 |
| Performance score | 4 (better) | 1 |
| Health score | 2 (better) | 0 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 78.7× | – |
| P/S | 4.7× (better) | 5.5× |
| P/B | 3.2× | 1.5× (better) |
| EV/EBITDA | 16.0× | – |
| Fair value | $23.17 | $16.35 |
| Margin of safety | −131% | −10.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 16.4% (better) | −5.8% |
| Revenue growth, 5Y average | 16.2% | 18.8% (better) |
| EPS growth, 5Y average | 53.1% | – |
| Profitability | ||
| Gross margin | 21.2% | – |
| Operating margin | 19.2% | – |
| Net margin | 4.8% (better) | −4.0% |
| Return on equity | 4.0% (better) | −1.0% |
| Return on invested capital | 16.5% | – |
| Financial health | ||
| Interest coverage | 6.2× | – |
| Altman Z-score | 3.89 (better) | 0.90 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | 5.3% (better) |
| Payout ratio | 148% | – |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 3.1% (better) | −1.7% |
| Buyback yield | −11.5% | 0.05% (better) |
| Shareholder yield | −9.6% | 5.3% (better) |
| Ownership | ||
| Held by institutions | 103% | 110% |
| Held by insiders | 0.63% | 4.9% |
| Insider net buying, 12 months | −$5.5M | −$745K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 14.7% | 5.8% |
Go deeper
- AHR stock overview
- AHR income statement
- AHR valuation and score
- HR stock overview
- HR income statement
- HR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.